Four mosquito-borne virus assay gets FDA Emergency Use Authorization
by Press Release from Outbreak News Today on (#2Z7YA)
The Center for Infection and Immunity (CII) at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and ["]
The post Four mosquito-borne virus assay gets FDA Emergency Use Authorization appeared first on Outbreak News Today.